GBT’s Oxbryta™ (voxelotor) tablets is approved for the treatment of sickle cell disease

Oxbryta™ (voxelotor) tablets Now Approved On behalf of GBT, we are happy to share that Oxbryta (pronounced ox-brye-ta) is now approved by the U.S. Food and Drug Administration (FDA). Oxbryta [...]

December 3, 2019

CRISPR Therapeutics and Vertex Announce Positive Safety and Efficacy Data

Nov 19, 2019 CRISPR Therapeutics and Vertex Announce Positive Safety and Efficacy Data From First Two Patients Treated With Investigational CRISPR/Cas9 Gene-Editing Therapy CTX001® for Severe Hemoglobinopathies -Two patients treated [...]

November 19, 2019

Novartis Adakveo approved by FDA for Sickle Cell Disease

New Novartis medicine Adakveo® (crizanlizumab-tmca) approved by FDA to reduce frequency of pain crises in individuals living with sickle cell disease Sickle cell pain crises are unpredictable, severe events associated with [...]

November 16, 2019

Donate Blood to Support Sickle Cell Patients

September is Sickle Cell Awareness Month; Red Cross blood and platelet donations needed for patients This school year students battling sickle cell disease and childhood cancers prepare to face challenges [...]

September 10, 2019

GBT and SCDAA to Host 8th Annual Sickle Cell Disease (SCD) Therapeutics Conference

GlobalBlood Therapeutics, Inc. (GBT) (NASDAQ: GBT) and the Sickle Cell Disease Association of America, Inc. (SCDAA) announced that they will host the 8th Annual Sickle Cell Disease (SCD) Therapeutics Conference [...]

September 5, 2019

SCDAA Forms International Media Partnership to Spread SCD Awareness

New International Media Partnership Will Enhance Awareness Efforts and Increase Awareness about Sickle Cell Disease and Sickle Cell Trait Sickle Cell Disease Association of America, Inc. (SCDAA) and the African [...]

July 16, 2019

SCDAA Partners with The Pain Community to Support the Sickle Cell Community by Providing Comprehensive Integrative Pain Management Educational Information

Sickle Cell Disease Association of America, Inc. (SCDAA) and The Pain Community are proud to announce a new partnership that will increase education and awareness information about comprehensive integrative pain [...]

July 11, 2019

GBT and Advocates Launch Disease Awareness Campaign Focused on Breaking Down Stigmas Associated with Sickle Cell Disease

Company Also Launches Disease Awareness Campaign to Raise Awareness Among Physicians About the Silent Damage Caused by Sickle Cell Disease Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT), in partnership with [...]

July 11, 2019

BLACKDOCTOR.ORG is a New Media Partner of the Sickle Cell Disease Association of America, Inc.

New National Media Partnership Will Enhance Awareness Efforts and Increase Awareness about Sickle Cell Disease and Sickle Cell Trait Sickle Cell Disease Association of America, Inc. (SCDAA) and BLACKDOCTOR.ORG are proud [...]

June 28, 2019

Novartis Unveils “The Untold Stories of Sickle Cell Disease,” a worldwide patient story project.

On June 19, 2019, for World Sickle Cell Awareness Day, Novartis unveiled "The Untold Stories of Sickle Cell Disease," a worldwide patient story project. This unique program offers a powerful [...]

June 21, 2019

(800) 421-8453

info@sicklecelldisease.org

SCDAA Member

Clinical Trial Finder

News